Syros Pharmaceuticals Management
Management criteria checks 2/4
Syros Pharmaceuticals' CEO is Conley Chee, appointed in Dec 2023, has a tenure of less than a year. directly owns 0.085% of the company’s shares, worth $106.22K. The average tenure of the management team and the board of directors is 2 years and 11 years respectively.
Key information
Conley Chee
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.09% |
| Management average tenure | 2yrs |
| Board average tenure | 11yrs |
Recent management updates
Recent updates
Syros Pharmaceuticals: Rising Despite Dilution, A Must Look
Jan 14Syros Pharmaceuticals: A Major Vote Of Confidence From Insiders
Sep 20Syros gets FDA orphan drug designation for pancreatic cancer treatment SY-5609
Sep 13Syros Pharmaceuticals Q2 2022 Earnings Preview
Aug 08Syros Pharmaceuticals Is A Buy As New Trials Start
Nov 20Syros Pharmaceuticals (NASDAQ:SYRS) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Nov 08
Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 02Syros Pharma up 18% day after ARK Innovation dumps shares
May 27Analysts Just Made A Substantial Upgrade To Their Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Forecasts
May 11Does Syros Pharmaceuticals (NASDAQ:SYRS) Have A Healthy Balance Sheet?
May 07CEO
Conley Chee (53 yo)
less than a year
Tenure
Mr. Conley Chee serves as President, Chief Executive Officer & Director at Syros Pharmaceuticals, Inc. since December 02, 203. He served as Chief Commercial Officer at Syros Pharmaceuticals, Inc. since Sep...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Scientific Founder | no data | US$239.66k | 0.15% $ 183.3k | |
| Chief Medical Officer | 8.3yrs | US$1.76m | no data | |
| CEO, President & Director | less than a year | no data | 0.085% $ 106.2k | |
| Founder | no data | no data | no data | |
| Scientific Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Chief Financial Officer | 2.5yrs | US$2.82m | 0.093% $ 115.9k | |
| Director of Corporate Communications & Investor Relations | no data | no data | no data | |
| Chief Legal Officer & Head of Business Development | 1.5yrs | US$1.46m | 0.15% $ 187.7k | |
| Vice President of Human Resources | 1.3yrs | no data | no data | |
| Chief Development Officer | 3.8yrs | no data | 0.095% $ 119.1k |
2.0yrs
Average Tenure
55yo
Average Age
Experienced Management: SYRS's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Scientific Founder | 12.4yrs | US$239.66k | 0.15% $ 183.3k | |
| CEO, President & Director | less than a year | no data | 0.085% $ 106.2k | |
| Scientific Founder & Member of Scientific Advisory Board | 11yrs | no data | no data | |
| Independent Chairman | 7.3yrs | US$211.28k | 0.045% $ 56.6k | |
| Member of Scientific Advisory Board | 11yrs | no data | no data | |
| Independent Director | 1.6yrs | US$135.67k | 0.045% $ 56.6k | |
| Director | 11yrs | US$3.49m | 0.50% $ 621.4k | |
| Member of Scientific Advisory Board | 11yrs | no data | no data | |
| Member of Scientific Advisory Board | 11yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 11yrs | no data | no data | |
| Member of Scientific Advisory Board | 11yrs | no data | no data |
11.0yrs
Average Tenure
62.5yo
Average Age
Experienced Board: SYRS's board of directors are seasoned and experienced ( 11 years average tenure).